On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Cancer therapeutics and mechanisms

TopicLeading institutions, researchers & key papers

Cancer therapeutics and mechanisms is a topic indexed in ScholarIQ from OpenAlex.

What is known about Cancer therapeutics and mechanisms?

ScholarIQrecord summary

This cluster of papers focuses on the structure, function, inhibition, and genetic variants of DNA topoisomerases, particularly their roles in chemotherapy, the mechanism of action of specific inhibitors such as irinotecan and quinolones, and their impact on genomic stability. The papers also explore the potential use of genetic variants in predicting drug toxicity and treatment outcomes.

How many works does Cancer therapeutics and mechanisms have?

ScholarIQindexed works

Cancer therapeutics and mechanisms has 174 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Cancer therapeutics and mechanisms?

ScholarIQopenalex

The OpenAlex for Cancer therapeutics and mechanisms is on the source record.

What are the most-cited papers on Cancer therapeutics and mechanisms?

ScholarIQmost cited works
Topoisomerase I inhibitors: camptothecins and beyond
Yves Pommier
Nature reviews. Cancer. 20062,258 CitationsOPEN ACCESS
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Yves Pommier, Elisabetta Leo, Hongliang Zhang, Christophe Marchand
Chemistry & Biology. 20101,842 CitationsOPEN ACCESS
Roles of eukaryotic topoisomerases in transcription, replication and genomic stability
Yves Pommier, Yilun Sun, Shar-yin N. Huang, John L. Nitiss
Nature Reviews Molecular Cell Biology. 2016982 CitationsOPEN ACCESS
Drugging Topoisomerases: Lessons and Challenges
Yves Pommier
ACS Chemical Biology. 2012837 Citations
Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation
Noritaka Tanaka, Jessica J. Lin, Chendi Li, Meagan B. Ryan, Junbing Zhang, Lesli A. Kiedrowski, Alexa Michel, Mohammed U. Syed, Katerina A. Fella, Mustafa Sakhi, Islam Baiev, Dejan Juric, Justin F. Gainor, Samuel J. Klempner, Jochen K. Lennerz, Giulia Siravegna, Liron Bar‐Peled, Aaron N. Hata, Rebecca S. Heist, Ryan B. Corcoran
Cancer Discovery. 2021526 CitationsOPEN ACCESS

Where is Cancer therapeutics and mechanisms research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Cancer therapeutics and mechanisms is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
20%
Hybrid
20%
Bronze
27%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial